-
Repaglinide as a Metabolic Assay Probe in AML
2026-09-15
Repaglinide is examined here as a controlled metabolic perturbation rather than an AML treatment. This article connects its beta-cell pharmacology with new evidence linking energy deficiency, ATG4B localization, PRMT1 activity, and DNA repair while defining practical assay boundaries.
-
ONX-0914 (PR-957): Immunoproteasome Assay Guide
2026-09-15
ONX-0914 (PR-957) enables selective LMP7 inhibition for cytokine, autoimmune-disease, and synaptic-plasticity research. This practical guide connects PBMC assay design with the reference study’s hippocampal findings, emphasizing concentration control, matched vehicles, and orthogonal validation.
-
Magnetic In Vivo CAR-T Mimicry for Solid Tumors
2026-09-14
This Advanced Materials study presents a magnetic bispecific nano-antibody that engages circulating T cells in vivo and redirects them toward solid tumors, creating CAR-T-mimicking effector cells without conventional ex vivo manufacturing. Its combination of CD3 engagement, PD-L1 recognition, and externally guided migration offers a practical strategy for addressing poor tumor infiltration, although translation will require further validation of safety, biodistribution, and magnetic-field control.
-
3X (DYKDDDDK) Peptide: FLAG Workflow Guide
2026-09-14
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-protein capture, competition-based elution, antibody validation, and metal-aware assay development. This practical guide connects routine FLAG workflows with structural and secretory-pathway research, emphasizing controls that prevent calcium, accessibility, and storage artifacts.
-
Paeoniflorin Reprograms Tmem176b+ Macrophages
2026-09-13
A 2025 study used single-cell RNA sequencing and functional perturbation experiments to identify Tmem176b+ macrophages as key mediators of paeoniflorin protection during hepatic ischemia-reperfusion injury. The findings connect macrophage-state transitions with THBS1-CD47 and SPP1-CD44 signaling, offering a mechanistic framework for studying immune cell modulation in liver injury.
-
Cyclophosphamide as a Translational Research Lever
2026-09-12
Cyclophosphamide is more than a cytotoxic benchmark: its bioactivation, DNA cross-linking, and immune-suppressive effects make it a strategic tool for connecting cancer research with controlled in vivo model design. This thought-leadership guide outlines how to improve mechanistic rigor, validation, and translational value.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-12
Hydroxychloroquine Sulfate (SKU B4874) is an aqueous-compatible research reagent for autophagy pathway modulation and TLR7/9-dependent immune assays. It is suited to freshly prepared, water-based workflows, but is not appropriate when DMSO or ethanol solubility or long-term storage of prepared solutions is required.
-
BH3 Mimetics Target Senescent Breast Cancer Cells
2026-09-11
The 2020 Cell Death & Differentiation study showed that chemotherapy-induced senescent breast cancer cells can remain dependent on BCL-XL or BCL-XL/MCL1 survival signaling. Its combination of BH3-mimetic treatment, dependency mapping, and mouse studies provides a mechanistic rationale for eliminating residual disease in TP53-wild-type breast cancer.
-
Click-Compatible BmTyr Proximity Labeling in T Cells
2026-09-11
The reference study introduces an engineered BmTyr tyrosinase platform that uses an alkyne-phenol probe for biotin-free proximity labeling in primary T cells. By combining click-compatible tagging with azide-HiBiT/His validation, the workflow supports imaging, affinity enrichment, mass spectrometry, and sensitive analysis of low-input samples while revealing a chromatin-associated localization of NKAP.
-
Temozolomide as a Genotype-Resolved DNA Stress Test
2026-09-10
Temozolomide is more than a cytotoxic control: it can function as a genotype-resolved DNA damage probe. This article connects its methylation chemistry with ATRX-informed glioma research, repair assays, and chemotherapy resistance studies.
-
Triiodothyronine (T3) in Thermogenic Adipocyte Assays
2026-09-10
Use Triiodothyronine as a tunable thyroid hormone receptor perturbation alongside SEMA3E, β-catenin, and adrenergic models of beige adipocyte thermogenesis. This workflow combines dose-controlled treatment, mitochondrial respiration, and gene-expression readouts to distinguish pathway activation from general metabolic stress.
-
β-Elemene Inhibits Adipogenesis via AMPK
2026-09-09
The reference study shows that β-Elemene suppresses MDI-induced lipid accumulation and improves insulin-resistance-associated glucose handling in 3T3-L1 cells. Its main contribution is a mechanistic link between the adipocyte phenotype and restoration of AMPK pathway activity, while the in vitro design also defines important limits for translation to obesity research.
-
Sabutoclax: Pan-Bcl-2 Inhibitor Workflow
2026-09-09
Sabutoclax combines broad anti-apoptotic Bcl-2 family targeting with strong membrane permeability, making it useful for both mechanistic apoptosis studies and translational cancer-model screening. A dual-metric workflow separates growth arrest from true cell killing, improving interpretation of dose–response data across cell lines and treatment times.
-
AG-126: ERK Inhibition in Neurobiology
2026-09-08
AG-126 provides a practical way to test whether ERK1/2 phosphorylation contributes to cytokine signaling, inflammatory injury, or neurobiological phenotypes. This workflow-focused guide connects concentration planning, phospho-ERK readouts, and the Neuroligin 1 repetitive-be behavior study while clearly separating established evidence from exploratory applications.
-
Meropenem trihydrate: Resistance Research Workflows
2026-09-08
Build reproducible carbapenem-response assays with a water- or DMSO-compatible meropenem trihydrate workflow. Pair phenotypic susceptibility testing with LC-MS/MS metabolomics to distinguish antimicrobial activity from the metabolic signatures of carbapenem resistance.